Published in Clin Infect Dis on December 01, 1997
The clinical importance of emerging Campylobacter species. Nat Rev Gastroenterol Hepatol (2011) 2.12
Global Epidemiology of Campylobacter Infection. Clin Microbiol Rev (2015) 1.73
Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother (2000) 1.64
Campylobacter fetus bloodstream infection: risk factors and clinical features. Eur J Clin Microbiol Infect Dis (2007) 1.23
Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis. Antimicrob Agents Chemother (2016) 1.15
A nationwide study of Campylobacter jejuni and Campylobacter coli bacteremia in Finland over a 10-year period, 1998-2007, with special reference to clinical characteristics and antimicrobial susceptibility. Clin Infect Dis (2011) 1.11
The role of serine protease HtrA in acute ulcerative enterocolitis and extra-intestinal immune responses during Campylobacter jejuni infection of gnotobiotic IL-10 deficient mice. Front Cell Infect Microbiol (2014) 1.05
An uncommon Helicobacter isolate from blood: evidence of a group of Helicobacter spp. pathogenic in AIDS patients. J Clin Microbiol (1999) 1.01
Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice. Eur J Microbiol Immunol (Bp) (2013) 1.01
gyrA polymorphism in Campylobacter jejuni: detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing. Antimicrob Agents Chemother (2002) 0.94
The impact of serine protease HtrA in apoptosis, intestinal immune responses and extra-intestinal histopathology during Campylobacter jejuni infection of infant mice. Gut Pathog (2014) 0.91
Molecular typing of Campylobacter jejuni isolates involved in a neonatal outbreak indicates nosocomial transmission. J Clin Microbiol (2003) 0.91
So close and yet so far - Molecular Microbiology of Campylobacter fetus subspecies. Eur J Microbiol Immunol (Bp) (2012) 0.88
Acute and chronic histological changes of the small bowel secondary to C. jejuni infection in a rat model for post-infectious IBS. Dig Dis Sci (2011) 0.88
Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. World J Hepatol (2012) 0.87
Campylobacter bacteremia: a rare and under-reported event? Eur J Microbiol Immunol (Bp) (2012) 0.87
Pediatric campylobacteriosis in northern Taiwan from 2003 to 2005. BMC Infect Dis (2008) 0.85
Spondylodiscitis and an aortic aneurysm due to Campylobacter coli. Ann Clin Microbiol Antimicrob (2010) 0.84
Effects of lipooligosaccharide inner core truncation on bile resistance and chick colonization by Campylobacter jejuni. PLoS One (2013) 0.83
A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature. Eur J Clin Microbiol Infect Dis (2004) 0.83
Bacterial infections in cirrhosis: A critical review and practical guidance. World J Hepatol (2016) 0.83
Contribution of TAT system translocated PhoX to Campylobacter jejuni phosphate metabolism and resilience to environmental stresses. PLoS One (2011) 0.79
Fatal relapse of a purulent pleurisy caused by Campylobacter fetus subsp. fetus. J Clin Microbiol (2007) 0.77
Campylobacter fetus infection presenting with bacteremia and cellulitis in a 72-year-old man with an implanted pacemaker: a case report. J Med Case Rep (2012) 0.77
Retracted Aortic homograft endocarditis caused by Campylobacter jejuni. J Clin Microbiol (2011) 0.75
Campylobacter fetus Bacteremia Revealed by Cellulitis without Gastrointestinal Symptoms in the Context of Acquired Hypogammaglobulinemia: A Report of Three Cases. Case Rep Gastrointest Med (2011) 0.75
Campylobacter jejuni Bacteremia in a Patient With Acute Lymphocytic Leukemia. Iran Red Crescent Med J (2016) 0.75
An unusual cause of spontaneous bacterial peritonitis due to Campylobacter fetus with alcoholic liver cirrhosis. BMJ Case Rep (2013) 0.75
Beyond Campylobacter jejuni: understanding Campylobacter coli infections in a systemic model of disease. Virulence (2015) 0.75
Clinical and epidemiological analysis of Campylobacter fetus subsp. fetus infections in humans and comparative genetic analysis with strains isolated from cattle. BMC Infect Dis (2016) 0.75
Recurrent Campylobacter jejuni bacteremia in a patient with hypogammaglobulinemia: A case report. Medicine (Baltimore) (2017) 0.75
Septic Shock with Multi Organ Failure Due to Fluoroquinolones Resistant Campylobacter Jejuni. Am J Case Rep (2017) 0.75
Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. Am J Med (1996) 2.36
Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study. Ann Intern Med (1992) 1.67
Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother (2007) 1.66
Cytomegalovirus disease as a risk factor for graft loss and death after orthotopic liver transplantation. Clin Infect Dis (1998) 1.57
Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy. Arch Intern Med (1999) 1.53
Current understanding and management of chronic hepatosplenic suppurative brucellosis. Clin Infect Dis (2001) 1.51
Impact of early central venous catheter removal on outcome in patients with candidaemia. Clin Microbiol Infect (2007) 1.43
[Treatment and outcome of pneumococcal meningitis in adults. Study of a recent series of 70 episodes]. Med Clin (Barc) (1995) 1.43
Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation. Transpl Infect Dis (2014) 1.41
[Treatment of community acquired acute uncomplicated pyelonephritis]. Med Clin (Barc) (1999) 1.40
[Defence mechanisms against meningococcus]. Med Clin (Barc) (1995) 1.39
Streptococcus agalactiae infective endocarditis: analysis of 30 cases and review of the literature, 1962-1998. Clin Infect Dis (2002) 1.35
Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol (1999) 1.32
Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis. J Acquir Immune Defic Syndr (2001) 1.32
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrob Agents Chemother (2008) 1.29
Nontuberculous mycobacterial meningitis: report of two cases and review. Clin Infect Dis (1996) 1.26
Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrob Agents Chemother (1996) 1.24
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect (2013) 1.23
Clinical outcome and long-term prognosis of late prosthetic valve endocarditis: a 20-year experience. Clin Infect Dis (1997) 1.22
Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users. Arch Intern Med (1998) 1.17
Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non- Pneumocystis carinii pneumonia in AIDS patients. Eur Radiol (2002) 1.16
Rhodococcus equi pneumonia in patients infected with the human immunodeficiency virus. Report of 2 cases and review of the literature. Scand J Infect Dis (1997) 1.14
Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant (1993) 1.14
Adenosine deaminase activity in rheumatoid pleural effusion. Ann Rheum Dis (1988) 1.12
Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis (2005) 1.11
Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura. Eur J Clin Microbiol Infect Dis (2000) 1.10
Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur J Clin Microbiol Infect Dis (1992) 1.07
Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides. Antimicrob Agents Chemother (1999) 1.04
Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin. J Antimicrob Chemother (2013) 1.03
Immunosuppressive therapy and infection after kidney transplantation. Transpl Infect Dis (2010) 1.01
Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin. Antimicrob Agents Chemother (1995) 1.00
Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob Agents Chemother (1993) 0.97
Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain. Clin Microbiol Infect (2010) 0.97
Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ann Intern Med (1996) 0.97
Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats. Antimicrob Agents Chemother (1997) 0.96
Management of catheter-related Staphylococcus aureus bacteremia: when may sonographic study be unnecessary? Eur J Clin Microbiol Infect Dis (2003) 0.96
Favorable prognosis of purulent meningitis in patients infected with human immunodeficiency virus. Clin Infect Dis (1998) 0.94
Trypanosoma cruzi infection in a non-endemic country: epidemiological and clinical profile. Clin Microbiol Infect (2013) 0.94
Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients. J Viral Hepat (2007) 0.94
Is the clinical spectrum and prognosis of native valve infective endocarditis in non-addicts changing? Eur Heart J (1995) 0.93
Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique. Clin Microbiol Infect (2001) 0.93
Multicentric giant follicular lymph node hyperplasia. Favorable response to radiotherapy. Cancer (1983) 0.92
Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy. Clin Microbiol Infect (2013) 0.92
Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. J Heart Lung Transplant (2001) 0.91
Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome. HIV Med (2008) 0.90
Donor-to-host transmission of bacterial and fungal infections in lung transplantation. Am J Transplant (2006) 0.90
Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group. Am J Transplant (2007) 0.90
Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin Infect Dis (1999) 0.89
Ceftriaxone-associated biliary pseudolithiasis in adults. Lancet (1989) 0.89
Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia. Clin Microbiol Infect (2012) 0.88
[Infections in 96 cases of systemic lupus erythematosus]. Med Clin (Barc) (1990) 0.88
Postpartum retroperitoneal abscess due to Mycoplasma hominis. Clin Infect Dis (1995) 0.88
Sternotomy infection due to Mycoplasma hominis and Ureaplasma urealyticum. Eur J Clin Microbiol Infect Dis (1995) 0.88
Prognosis of enterococcal endocarditis. Rev Infect Dis (1992) 0.87
Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital. HIV Med (2012) 0.87
A multicenter study of valganciclovir prophylaxis up to day 120 in CMV-seropositive lung transplant recipients. Am J Transplant (2009) 0.86
Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother (2013) 0.86
Impact of a multimodal intervention to reduce bloodstream infections related to vascular catheters in non-ICU wards: a multicentre study. Clin Microbiol Infect (2012) 0.85
Incidence and risk factors of recurrent episodes of bacteremia in adults. Arch Intern Med (1994) 0.84
Streptococcus bovis bacteremia and digestive system neoplasms. Scand J Infect Dis (1988) 0.84
Osteomyelitis of the jaw: resistance to clindamycin in patients with prior antibiotics exposure. Eur J Clin Microbiol Infect Dis (2008) 0.84
Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis. Antimicrob Agents Chemother (2001) 0.84
Donor infection and transmission to the recipient of a solid allograft. Am J Transplant (2008) 0.83
Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital--prospective analysis of referral bias and influence of inadequate antimicrobial treatment. Clin Microbiol Infect (2011) 0.82
Streptococcus bovis endocarditis presenting as acute spondylodiscitis. Br J Rheumatol (1994) 0.82
A pilot double-blind, randomized, and placebo-controlled study of orally administered IFN-alpha-n1 (Ins) in pediatric patients with measles. J Interferon Cytokine Res (1998) 0.82
Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (2001) 0.82
Empyema due to splenic abscess in typhoid fever. Br Med J (1977) 0.81
Clinical considerations regarding infective Libman-Sacks endocarditis. Int J Cardiol (1985) 0.81
Autoimmune neutropenia and thrombocytopenia associated with development of antibodies to human immunodeficiency virus. J Infect (1989) 0.81
Clinical and molecular epidemiology of community-acquired, healthcare-associated and nosocomial methicillin-resistant Staphylococus aureus in Spain. Clin Microbiol Infect (2009) 0.81